Featured

Intelligent technologies are transforming the pharmaceutical industry at a company and sector level, where tools such as artificial intelligence, machine learning and blockchain are pushing the limits of data analysis and accelerating decision-making. Meanwhile, similar technological progress is also...

The most common way to deliver a drug is systemically via an oral tablet or injection. In many cases, delivery of a drug via these routes may not be possible (poor bioavailability) or desirable (due to side effects); In...

The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products. At the same time, innovative analytical technologies have been developed that offer new...

Ultra high barrier films protect any dosage content The Pharmaceutical Industry has always mainly focused on novel drug research, formulation development,  and  subsequent  clinical  trials.  As  with  all  other  phases  it  presents  its  own  challenges. There is no use if...

Anticipate New Compliance Standards Now or Risk Falling Behind Overview While showing significant promise, regenerative medicine materials are inherently fragile and more at risk than other products during the supply chain process. Cross-contamination, orientation and handling problems, and equipment failure...

1. Recent studies suggest great therapeutic potential of educating and unleashing our own immune system for cancer treatment; is this a holistic way forward? Many of those involved in cancer research are coming to the opinion that an appropriate mode...

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel. Over their development history, the therapeutic performance and value of DEDs has evolved significantly, and recent innovation has...